| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer
|
Akerley, Wallace
|
|
2008
|
9 |
5 |
p. 306-
1 p.
|
article
|
| 2 |
A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors
|
Lee, Dae Ho
|
|
2008
|
9 |
5 |
p. 297-
1 p.
|
article
|
| 3 |
Can We Detect Lung Cancer Earlier by Measurement of Serum C-Reactive Protein, Carcinoembryonic Antigen, and Cell-Free Plasma DNA?
|
Son, Choonhee
|
|
2008
|
9 |
5 |
p. 301-
1 p.
|
article
|
| 4 |
Conformal Radiation Therapy as Definitive Treatment of Stage I Non—Small-Cell Lung Cancer: University of California San Diego Experience
|
Sandhu, Ajay
|
|
2008
|
9 |
5 |
p. 299-
1 p.
|
article
|
| 5 |
Developing an Effective Lung Cancer Program in a Community Hospital Setting
|
Fischel, Richard J.
|
|
2008
|
9 |
5 |
p. 291-
1 p.
|
article
|
| 6 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as a First-Line Therapy for Never-Smokers with Adenocarcinoma of the Lung and Asymptomatic Synchronous Brain Metastasis
|
Lee, Dae Ho
|
|
2008
|
9 |
5 |
p. 296-
1 p.
|
article
|
| 7 |
Erratum
|
|
|
2008
|
9 |
5 |
p. 307-
1 p.
|
article
|
| 8 |
Exosomal microRNA: A Diagnostic Marker for Lung Cancer
|
Kloecker, Goetz H.
|
|
2008
|
9 |
5 |
p. 295-
1 p.
|
article
|
| 9 |
Extensive-Stage Small-Cell Lung Cancer: Evolution of Systemic Therapy and Future Directions
|
Allen, Jeffrey
|
|
2008
|
9 |
5 |
p. 262-270
9 p.
|
article
|
| 10 |
First Report of Worldwide Use of Internet-Based Survivorship Care Plans by Lung Cancer Survivors
|
Metz, J.M.
|
|
2008
|
9 |
5 |
p. 298-
1 p.
|
article
|
| 11 |
Highlights from: The Addario Lung Cancer Medical Institute Summit; June 17, 2008
|
McGill, Catherine
|
|
2008
|
9 |
5 |
p. 254-256
3 p.
|
article
|
| 12 |
Instructions to Authors
|
|
|
2008
|
9 |
5 |
p. 309-310
2 p.
|
article
|
| 13 |
Metronomic Chemotherapy in Patients with Advanced Non—Small-Cell Lung Cancer Associated with Long-Term Survival
|
Chen, Nick
|
|
2008
|
9 |
5 |
p. 290-
1 p.
|
article
|
| 14 |
New Targeted Therapies and Small-Cell Lung Cancer
|
Rossi, Antonio
|
|
2008
|
9 |
5 |
p. 271-279
9 p.
|
article
|
| 15 |
Patterns of Radiation Therapy Practice in Nonmetastatic Non—Small-Cell Lung Cancer: Results of Web-Based Patterns of Care Study in Korea
|
Wu, Hong-Gyun
|
|
2008
|
9 |
5 |
p. 304-
1 p.
|
article
|
| 16 |
Preliminary Treatment Patterns and Safety Outcomes for Non—Small-Cell Lung Cancer from ARIES, a Bevacizumab Treatment Observational Cohort Study
|
Spigel, David
|
|
2008
|
9 |
5 |
p. 302-
1 p.
|
article
|
| 17 |
Primary Pleuropulmonary Synovial Sarcoma
|
Mirzoyan, Michael
|
|
2008
|
9 |
5 |
p. 257-261
5 p.
|
article
|
| 18 |
Retraction Notice
|
Mathur, Sohrab S.
|
|
2008
|
9 |
5 |
p. 308-
1 p.
|
article
|
| 19 |
Single-Agent Epidermal Growth Factor Receptor Inhibitor Gefitinib for the Treatment of Patients with Advanced Non—Small-Cell Lung Cancer and Poor Performance Status
|
Karim, Nagla Abdel
|
|
2008
|
9 |
5 |
p. 293-294
2 p.
|
article
|
| 20 |
Small Cell, Big Problem! Stem Cells, Root Cause?
|
Subramanian, Janakiraman
|
|
2008
|
9 |
5 |
p. 252-253
2 p.
|
article
|
| 21 |
Sunitinib plus Erlotinib for the Treatment of Metastatic Non—Small-Cell Lung Cancer: A Novel VEGFR—EGFR Co-Inhibition Treatment Strategy
|
Scagliotti, Giorgio V.
|
|
2008
|
9 |
5 |
p. 300-
1 p.
|
article
|
| 22 |
Symptom Concerns and Use of Supportive Services in Patients with Lung Cancer
|
Borneman, Tami
|
|
2008
|
9 |
5 |
p. 288-
1 p.
|
article
|
| 23 |
Targeting Dishevelled, a mediator of Wnt/β-Catenin Signaling Pathway, in Human Non—Small-Cell Lung Cancer
|
Chen, Zhao
|
|
2008
|
9 |
5 |
p. 305-
1 p.
|
article
|
| 24 |
Targeting Wnt-2 in Mesothelioma and Lung Cancer
|
Bravo, Dawn T.
|
|
2008
|
9 |
5 |
p. 289-
1 p.
|
article
|
| 25 |
The Clinical Development of Vandetanib: Updates on Ongoing Phase III Clinical Trials in Advanced Non—Small-Cell Lung Cancer
|
Heymach, John
|
|
2008
|
9 |
5 |
p. 292-
1 p.
|
article
|
| 26 |
Tracheoesophageal Fistula Development and Concurrent Chemoradiation and Bevacizumab in Non—Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2008
|
9 |
5 |
p. 303-
1 p.
|
article
|
| 27 |
Unusual Tumor Response and Toxicity from Radiation and Concurrent Erlotinib for Non–Small-Cell Lung Cancer
|
Nanda, Akash
|
|
2008
|
9 |
5 |
p. 285-287
3 p.
|
article
|
| 28 |
Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study
|
Rossi, David
|
|
2008
|
9 |
5 |
p. 280-284
5 p.
|
article
|
| 29 |
Will FLEX Allow Us Flexibility in the Therapy of Advanced Non–Small-Cell Lung Cancer? Insights from the 2008 American Society of Clinical Oncology Meeting
|
Langer, Corey J.
|
|
2008
|
9 |
5 |
p. 249-251
3 p.
|
article
|
Journal description